UCLA researchers demonstrated an enhancer-targeted CRISPR activation approach (dCas9-p300) intended to boost haploinsufficient autism genes without DNA cutting. In human neuron and cerebral organoid models carrying CHD8 or SCN2A mutations, the method produced sustained increases in gene expression and rescued key gene-expression phenotypes, including restored excitability in SCN2A-mutant neurons.
Get the Daily Brief